According to a recently published report, the Global Healthcare Analytical Testing Services Market is expected to grow $4710 million till 2022 with the CAGR of 12.1% during 2016-2022. The segmentation of global healthcare analytical testing services market is based on type, end users, sample and regional outlook. The report on global healthcare analytical testing services market forecast 2016-2022 (type, end users, sample and regional outlook) provides detailed overview and predictive analysis of the market.
Detailed study on this Report : http://www.briskinsights.com/report/healthcare-analytical-testing-services-market
Healthcare industry is growing at a faster pace owing to increase in several chronic diseases. Healthcare analytics has multitude of issues and challenges coming in the current scenario where pressure related to regulations on healthcare insurance and provider companies, resource crunches, consolidation of the health records and operational advantages towards the healthcare industry in terms of revenue management cycle, diseases surveillance etc.Besides it, there are many other domains where healthcare analytics testing services are used widely. The application of analytics is growing at a rapid rate in healthcare sector. Healthcare analytics can be an effective tool for classifying population to cater public health priorities on the basis of epidemiological. It can be of immense use for empowering patients with rights, national preventive care, health policy recommendation, efficient government investment in healthcare infrastructure, public health financing, and ensuring easy enforcement of laws related to healthcare for patient’s protection in developing countries.
For Same Category Reports Visit Here: http://www.briskinsights.com/category/healthcare-market
Scope of the report
- GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY TYPE 2012 – 2022 ($ million)
1.1. Bio analytical Testing Services
1.1.1. Cell Based Assays
1.1.2. Virology Testing
1.1.3. Method Development Optimization And Validation
1.1.4. Immunogenecity And Neutralizing Antibody Testing
1.1.5. Biomarker Testing
1.1.6. Pharmacokinetic Testing
1.2. Physical Characterization Services
1.2.1. Laser Particle Size Analysis
1.2.2. Thermal Analysis
1.2.3. Image Analysis
1.2.4. Surface Area Analysis
1.3. Method Validation
1.3.1. Extractable & Leachable Method Development And Validation
1.3.2. Process Impurity Method Development And Validation
1.3.3. Cleaning Validation Method Development
1.3.4. Analytical Standard Characterization
1.3.5. Peak Identification
1.3.6. Technical Consulting
1.3.7. Other Method Validation Services
1.4. Raw Material Testing
1.4.1. Complete Compendial Testing
1.4.2. Heavy Metal Testing
1.4.3. Container Testing
1.4.4. Karl Fischer Analysis
1.4.5. Wet Chemistry Analysis
1.4.6. Other Raw Material Testing Services
1.5. Batch Release Testing Services
1.5.1. Dissolution Testing
1.5.2. Physical Tests
1.5.3. Elemental Impurity Testing
1.5.4. Disintegration Testing
1.5.5. Hardness Testing
1.5.6. Friability Testing
1.6. Stability Testing
1.6.1. Drug Substance Stability Testing
1.6.2. Formulation Evaluation Stability Testing
1.6.3. Stability Indicating Method Validation
1.6.4. Accelerated Stability Testing
1.6.5. Photostability Testing
1.6.6. Other Stability Testing Services
1.7. Microbial Testing
1.7.1. Microbial Limit Testing
1.7.2. Sterility Testing
1.7.3. Endotoxin Testing
1.7.4. Preservative Efficacy Testing
1.7.5. Water Testing
1.7.6. Other Microbial Testing Services
1.8. Environmental Monitoring
1.8.1. Air Testing
1.8.2. Wastewater/Etp Testing
1.8.3. Other Environmental Monitoring Services - GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY END USERS 2012 – 2022 ($ million)
2.1. Pharmaceutical And Biopharmaceutical Companies
2.2. Medical Devices Companies
2.3. Contract Research Organizations - GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY SAMPLE 2012 – 2022 ($ million)
3.1. Raw materials
3.2. Finished products
3.3. In process sample
3.4. Environmental samples - GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKETREGIONAL OUTLOOK 2012-2022($ million)
4.1. North America
4.2. Europe
4.3. Asia Pacific
4.4. Rest of the world - COMPANY PROFILES
5.1. Anabiotec
5.2. Bayer healthcare
5.3. Bioreliance Corporation (Merck KGAA)
5.4. Charles River Laboratories International Inc.
5.5. Envigo
5.6. Eurofins Scientific SE
5.7. Exova Group PLC
5.8. Intertek Group PLC.
5.9. Medistri SA
5.10. NSF health science
5.11. Pace Analytical Services Inc.
5.12. PPD Inc.
5.13. SGS
5.14. Source Bioscience
5.15. WUXI Pharmatech (Cayman) Inc.
Related Reports:
- http://www.briskinsights.com/report/healthcare-mobility-solutions-market
- http://www.briskinsights.com/report/care-management-solution-market
About Us :
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.
Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.
Contact Us :
Jennifer Smith
Office 1094
109 Vernon House
Friar Lane
Nottingham
NG1 6DQ
United Kingdom
Phone : +448081890034 (UK)
Email : sales@briskinsights.com
Website : http://www.briskinsights.com/